INNZ MEDICAL AS
Score · fiscal year 2025
72of 100
How to read this: the company is ahead of 90 % of small companies in the same sector in 2025. What does this mean?
Rank: 3,857 of 38,671 · Handel
Profile
Lion · Leader
High profitability, high solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 66 and solidity 66 out of 100 among small companies in the same sector in 2025. Methodology
Against the sector
INNZ MEDICAL AS is 22 points above the median for small companies in the same sector in 2025.
Median score 50 among 36,111 companies.
Against small companies in the same sector in 2025: operating margin 4.2% (median 2.5%) and equity ratio 63.6% (median 38.3%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 27 MNOK | 3 MNOK |
| Operating margin | 4.2% | 2.5% |
| Profit margin | 4.2% | 2.2% |
| Return on assets | 15.1% | 4.0% |
| Equity ratio | 63.6% | 38.3% |
| Debt-to-equity | 0.57 | 0.99 |
| Current ratio | 3.10 | 1.70 |
| Revenue growth | 59.0% | 3.5% |
| Revenue per employee | 5.48 MNOK | 1.62 MNOK |
The median and “ahead of” refer to small companies in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 72, INNZ MEDICAL AS does better than 90% of small companies in the same sector (36,580 companies) in 2025.
Score 2023–2025
- INNZ MEDICAL AS
- Median: small companies in the same sector
INNZ MEDICAL AS has a score of 72 for 2025, rank 3,857 of 38,671 in the sector.
Strongest: Growth: percentile 88 against peers, revenue growth 59.0% against a median of 3.5%. Consistency: percentile 80 against peers.
No area is clearly below its peers.
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
INNZ MEDICAL AS had an operating margin of 4.2% and an equity ratio of 63.6% in 2025, and ranks 3,857 of 38,671 in Handel.
From 2024 to 2025: revenue grew by 59% and the equity ratio rose from 43.1% to 63.6%.
This text is generated automatically from the 2025 accounts.
Three simple methods
The methods give between 6 MNOK and 9 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 9 MNOK |
| EV/EBIT | 8.0 | 9 MNOK |
| P/B | 1.0 | 6 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
No rules were triggered for this year.
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 6.9% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2017, the sector's weakest year, for this company.
The sector's weakest year was 2017, with a median operating margin of −65.6%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 66 | weight 30% |
|---|---|---|
| Solidity | 66 | weight 25% |
| Liquidity | 71 | weight 15% |
| Growth | 88 | weight 15% |
| Consistency | 80 | weight 15% |
Durability: 61 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is INNZ MEDICAL AS?
The operating margin was 4.2% in 2025, against a median of 2.5% among small companies in the same sector. Return on assets was 15.1%.
How solid is INNZ MEDICAL AS?
The equity ratio was 63.6% in 2025 (median 38.3%). Debt-to-equity was 0.57 (median 0.99).
What is the liquidity of INNZ MEDICAL AS like?
The current ratio was 3.10 in 2025 (median 1.70).
How does INNZ MEDICAL AS compare in Handel?
INNZ MEDICAL AS ranks 3,857 of 38,671 in Handel for 2025. Among companies of the same size (small companies) it ranks 3,632 of 36,580. Revenue changed by 59.0% from the year before.
Public contracts
- Contracts awarded since 2024
- 1
- Total awarded value since 2024
- value not stated
- 1 contracts without a stated value are not in the total.
| Date | Buyer | Notice | Value |
|---|---|---|---|
| 23 April 2025 | Sykehusbygg HF | K9570 Spesialutstyr Øye *KUNNGJØRING KONTRAKTSTILDELING* | value not stated |
Based on notices in Doffin. Does not show call-offs under framework agreements or purchases below the publication threshold. Values are as stated by the buyer.
Source: Doffin (DFØ), fetched 27 October 2026. Winners are matched on organisation number.
Contains data under the Norwegian licence for public data (NLOD 2.0) made available by Doffin/the Norwegian Agency for Public and Financial Management (DFØ). NLOD 2.0
From the Central Coordinating Register
- Org. no.
- 912586456
- Legal form
- AS
- Sector
- Handel (46.460)
- Size tier
- small
- Employees
- 5 registered 10 January 2025
- Founded
- 27 September 2013 13 years in operation
- Share capital
- 0.50 MNOK
- Business address
- Basbergveien 160, 3114 TØNSBERG
- Municipality
- Tønsberg rank 2 of 10 in KOSTRA group 11
- Latest accounts filed
- 2025
- Website
- www.innz.no
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chief executive
- Dag Støp Westnes
- Chair of the board
- Dag Støp Westnes
- Deputy member
- Dag Fredrik Ambro Westnes
- Deputy member
- Glenn Marius Westnes
- Auditor
- ENTER REVISJON AS
- Accountant
- SIMPLYGR8 AS
Source: Central Coordinating Register, fetched 25 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 26 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 62 | 50 | 72 | |
| Rank | 10,527 | 18,790 | 3,857 | |
| Operating margin | 3.1% | 2.1% | 4.2% | |
| Return on assets | 6.8% | 3.4% | 15.1% | |
| Equity ratio | 55.8% | 43.1% | 63.6% | |
| Current ratio | 2.48 | 1.83 | 3.10 | |
| Revenue growth | – | 0.3% | 59.0% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 17.2 MNOK | 17.2 MNOK | 27.4 MNOK |
| Operating profit | 0.5 MNOK | 0.4 MNOK | 1.2 MNOK |
| Profit before tax | 0.3 MNOK | 0.2 MNOK | 1.2 MNOK |
| Net profit | 0.2 MNOK | 0.1 MNOK | 0.9 MNOK |
| Financial expenses | 0.3 MNOK | 0.2 MNOK | 0.2 MNOK |
| Total assets | 8.7 MNOK | 11.6 MNOK | 9.2 MNOK |
| Current assets | 8.0 MNOK | 11.0 MNOK | 8.8 MNOK |
| Equity | 4.9 MNOK | 5.0 MNOK | 5.9 MNOK |
| Retained earnings | 4.4 MNOK | 4.5 MNOK | 5.4 MNOK |
| Total liabilities | 3.9 MNOK | 6.6 MNOK | 3.4 MNOK |
| Current liabilities | 3.2 MNOK | 6.0 MNOK | 2.8 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 26 October 2026, accounts id 7125529.
Further
Similar companies
- AHMED HOLDING AS index 72, rank 3,853 · compare
- HOS HAAKON AS index 72, rank 3,854 · compare
- COPYSAFE AS index 72, rank 3,855 · compare
- GJEDDA RETAIL CONSULTING AS index 72, rank 3,856 · compare
- FISKUM VED AS index 72, rank 3,858 · compare